Comparison
46 Xx Disorder Of Sex Development Skeletal Anomalies Syndrome C1849696 vs 3q13 Microdeletion Syndrome C2931338
Clinical comparison between 46 XX Disorder OF Sex Development Skeletal Anomalies Syndrome and 3q13 Microdeletion Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Skeletal Anomalies Syndrome C1849696
A rare genetic syndrome in XX individuals causing differences in sexual development alongside bone and skeletal abnormalities. It is present at birth and severe. Coordinated care with multiple specialists is essential.
3q13 Microdeletion Syndrome C2931338
A genetic disorder from missing material on chromosome 3q13, associated with developmental delays, intellectual disability, and various congenital features.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Skeletal Anomalies Syndrome C1849696
0-0
3q13 Microdeletion Syndrome C2931338
Variable
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Skeletal Anomalies Syndrome C1849696
severe
3q13 Microdeletion Syndrome C2931338
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Skeletal Anomalies Syndrome C1849696
Chronic
3q13 Microdeletion Syndrome C2931338
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Skeletal Anomalies Syndrome C1849696
No
3q13 Microdeletion Syndrome C2931338
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Skeletal Anomalies Syndrome C1849696
reproductive
3q13 Microdeletion Syndrome C2931338
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Skeletal Anomalies Syndrome C1849696
rare-disease
3q13 Microdeletion Syndrome C2931338
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-skeletal-anomalies-syndrome-C1849696 and 3q13-microdeletion-syndrome-C2931338 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Skeletal Anomalies Syndrome C1849696 | 3q13 Microdeletion Syndrome C2931338 | Discriminating power |
|---|---|---|---|
| Sex development | Differences of sex development in a 46,XX individual, present from birth. | Not a defining feature; genital findings are not established by the supplied description. | High |
| Skeletal findings | Bone and skeletal anomalies are a core reported feature. | Congenital features may occur, but skeletal involvement is not specifically established here. | Moderate |
| Neurodevelopment | Developmental delay is not established from the supplied description. | Developmental delay and intellectual disability are associated features. | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Skeletal Anomalies Syndrome C1849696 when
Newborn with atypical genital development and skeletal anomalies
This pairing matches the described syndrome better than isolated developmental delay.
Moderate
46,XX karyotype with a suspected rare DSD syndrome
The left concept specifically concerns XX sex development and skeletal findings.
Moderate
Severe congenital reproductive and skeletal phenotype
Supplied severity is severe, but exact features still need specialist confirmation.
Low
Choose 3q13 Microdeletion Syndrome C2931338 when
Developmental delay with intellectual disability and congenital anomalies
These are the features associated with 3q13 microdeletion in the source.
Moderate
Chromosomal microarray suggests loss at 3q13
A confirmed deletion supports this diagnosis over a clinical DSD label alone.
High
Variable-onset neurodevelopmental concerns without established DSD
Onset is listed as variable and sex-development findings are not defining.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Skeletal Anomalies Syndrome C1849696 | 3q13 Microdeletion Syndrome C2931338 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XX is part of the concept name; additional testing may still be needed. | Routine karyotype may be normal if the deletion is below its resolution. | A 46,XX result does not by itself diagnose either condition. |
| Chromosomal microarray | No specific deletion is established by the supplied data. | May identify missing material at 3q13 when present. | A confirmed 3q13 deletion supports the right diagnosis; absence needs clinician review. |
| Skeletal imaging and endocrine evaluation | Used to characterize reported bone anomalies and sex-development differences. | Selected according to individual congenital or developmental findings. | Abnormal results describe findings and do not alone prove a syndrome. |
Prognosis comparison
46 Xx Disorder Of Sex Development Skeletal Anomalies Syndrome C1849696
- Outcome
- A severe congenital course is described, but individual outcomes are not established.
- Factors
- Extent of sex-development differences, skeletal involvement, and access to coordinated care.
3q13 Microdeletion Syndrome C2931338
- Outcome
- Moderate severity is listed, with developmental impact that varies.
- Factors
- Deletion findings, developmental profile, congenital anomalies, and support services.
Time frame: Lifelong, with needs that may change from infancy through adulthood.
No reliable mortality or universal outcome can be stated from the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Reproductive and endocrine issues | May require coordinated specialist care because of differences in sex development. Not established as a typical complication from the supplied description. Individual assessment is required; do not assume fertility or hormone outcomes. |
| Skeletal complications | Bone abnormalities may affect growth, mobility, or orthopedic needs. Specific skeletal complications are not established here. Imaging and functional findings should guide care. |
| Developmental support needs | Neurodevelopmental impact is not established by the source. Delays and intellectual disability may require ongoing educational support. Support should follow assessed abilities rather than the syndrome label alone. |
Patient education highlights
- HighDiagnosis requires confirmation
Clinical features and genetic results must be interpreted by specialists; a comparison cannot confirm either diagnosis.
- HighCoordinated care
Genetics, endocrinology, orthopedics, and developmental services may be involved depending on findings.
- MediumVariable course
Both conditions are chronic, but severity and needs differ between people and over time.